Literature DB >> 30499393

Structure, Functions and Selective Inhibitors of HDAC6.

Tao Liang1, Hao Fang1.   

Abstract

Histone deacetylases 6 (HDAC6) has emerged as a promising target for the treatment of various human diseases including cancer, neurodegenerative disease and immunology due to its unique structure, substrate and biological functions. HDAC6 is involved in cell motility, cell survival, cell cycle progression, developmental events, prognosis as well as protein degradation and the involvement of HDAC6 in multiple biological processes has gained lots of attention. There is increasing interest in HDAC6 and its selective inhibitors. More than twenty years of synthetic efforts have developed various HDAC6 selective inhibitors with different Cap, linker and ZBG. This review will summarize recent research data regarding HDAC6 and various HDAC6 selective inhibitors. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Cancer; Epigenetics; HDAC6; HDAC6 selective inhibitors; Neurodegenerative disease; Protein degradation.

Mesh:

Substances:

Year:  2018        PMID: 30499393     DOI: 10.2174/1568026619666181129141822

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  6 in total

1.  HDACs control RUNX2 expression in cancer cells through redundant and cell context-dependent mechanisms.

Authors:  Gloria Manzotti; Federica Torricelli; Benedetta Donati; Valentina Sancisi; Mila Gugnoni; Alessia Ciarrocchi
Journal:  J Exp Clin Cancer Res       Date:  2019-08-08

2.  Histone Deacetylase 6 Knockout Mice Exhibit Higher Susceptibility to Influenza A Virus Infection.

Authors:  Mark Zanin; Jennifer DeBeauchamp; Gowthami Vangala; Richard J Webby; Matloob Husain
Journal:  Viruses       Date:  2020-07-06       Impact factor: 5.048

3.  Upregulated Histone Deacetylase 6 Associates with Malignant Progression of Melanoma and Predicts the Prognosis of Patients.

Authors:  Zhicheng Hu; Yanchao Rong; Shuting Li; Shanqiang Qu; Shaobin Huang
Journal:  Cancer Manag Res       Date:  2020-12-17       Impact factor: 3.989

4.  Study on pathogenic genes of dwarfism disease by next-generation sequencing.

Authors:  Lv-Lv Yang; Shi-Shan Liang
Journal:  World J Clin Cases       Date:  2021-03-06       Impact factor: 1.337

Review 5.  Next-generation of selective histone deacetylase inhibitors.

Authors:  Feifei Yang; Na Zhao; Di Ge; Yihua Chen
Journal:  RSC Adv       Date:  2019-06-24       Impact factor: 4.036

6.  Pharmacological Inhibition of HDAC6 Attenuates NLRP3 Inflammatory Response and Protects Dopaminergic Neurons in Experimental Models of Parkinson's Disease.

Authors:  Shaoqi Yan; Xinbing Wei; Wencheng Jian; Yue Qin; Jia Liu; Shaowei Zhu; Fan Jiang; Haiyan Lou; Bin Zhang
Journal:  Front Aging Neurosci       Date:  2020-03-31       Impact factor: 5.750

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.